See also this year's filing and all EDGAR filings for this company.
PDF Report 0001552189_2017_Panacea_LIFE_Sciences_Holdings_INC.pdf
Logs
| warning | The stock_price does not exist | industry.us_generic | {} |
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'NetIncome', 'value': -3860675, 'size_variable': 'Assets', 'size_value': 172673, 'ratio': 22.4, 'threshold': 20} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001552189')"} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('stock_price')"} |
Graph
Absolute values for 0001552189, Panacea LIFE Sciences Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | LiabilitiesNoncurrent | 0 |
| 1 | LiabilitiesCurrent | 624,974 |
| 2 | remainder_Liabilities | 0 |
| 3 | AssetsCurrent | 2,075,057 |
| 4 | AssetsNoncurrent | 0 |
| 5 | PropertyPlantAndEquipmentNet | 0 |
| 6 | Goodwill | 0 |
| 7 | remainder_Assets | 50,000 |
| 8 | GeneralAndAdministrativeExpense | 759,145 |
| 9 | ResearchAndDevelopmentExpense | 369,344 |
| 10 | remainder_Expenses | 472,997 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,453 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Liabilities | 624,974 |
| 1 | Assets | 2,125,057 |
| 2 | Expenses | 1,601,486 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 1,500,083 |
| 5 | NetIncome | -1,602,939 |
| 6 | ComprehensiveNetIncome | -1,602,939 |
| 7 | BaseVar | 2,176,485 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 0.329 |
| 9 | EconomicCapitalRatio | 1.16 |
Edgar->Model Mapping
Feature Distribution
Change over Time
